No Data
No Data
AbCellera Biologics Q4 2024 Earnings Preview
Earnings Preview: ABCL to Report Financial Results Post-market on February 27
AbCellera Biologics Changes COO's Title to Technology Chief
$ABCL Stock Is up 7% Today. Here's What We See in Our Data.
One AbCellera Biologics Insider Raised Their Stake In The Previous Year
Interest in AI-Powered MedTech is on the Rise: Key Stocks to Watch
Buy n Die Together❤ :
73610841 : Adrian Nathaniel carter, I can’t tag him and we’re Facebook friends, does anyone know why?
Seth Beaty : Though you know if you bet against Cathie Wood, you’ll probably make money.
Rob banks : is there an ETF for this ai medical sector?
Chak : is it goid time yo
get into TEM ?
View more comments...